Corporate Consulting

© 1999-2001
STAT America
All Rights Reserved
Some of the nation's largest corporations don't have the answers when it comes to justifying the screening program presently in place.  Questions arise concerning costs, the complexity of the process, and even the effectiveness of the program itself.  STAT America believes that any drug-screening program should pass the test of zero-based budgeting.  If substantial benefits are not derived from drug screening, the program is simply not worth the investment in time and dollars.  We will study your company and produce a definitive report that takes into account your company's location(s), industry trends, competitive concerns, and other important factors to help clarify where your company stands and in what direction we suggest it should turn relative to substance-abuse issues in the workplace.